BIIB

BIOGEN INC.

NasdaqGS · Healthcare

$205.70

-1.32% today

last filing 2026-06-09Pro sees filings in ~15 min

Price

hover · 4 moves explained

1 buy4 sells6 8-K

Analyst consensus

Buy

$219.27target+6.6%vs $205.70 today

$150.00 low today target$300.00 high

29 analysts · ~12-month consensus · as of May 28. Relayed analyst opinion, which tends to run optimistic — not our forecast or advice.

Earnings

Beat 4 of last 4

Earnings per share · actual vs forecast

Q2 '25+41.0%

$5.47

exp $3.88

Q3 '25+23.9%

$4.81

exp $3.88

Q4 '25+23.2%

$1.99

exp $1.62

Q1 '26+23.6%

$3.57

exp $2.89

Type	Date	Insider	Title	Of stake	Shares	Price	Value
Grant	2026-06-11	HAWKINS WILLIAM A	Director	—Direct	1,505	—	—
Grant	2026-06-11	SHERWIN STEPHEN A	Director	—Direct	1,505	—	—
Grant	2026-06-11	Rowinsky Eric K	Director	—Direct	1,505	—	—
Grant	2026-06-11	Mantas Jesus B	Director	—Direct	1,505	—	—
Grant	2026-06-11	LANGER SUSAN	Director	—Direct	1,505	—	—

Grant

HAWKINS WILLIAM A

Director · 2026-06-11

—

1,505 shares

Grant

SHERWIN STEPHEN A

Director · 2026-06-11

—

1,505 shares

Grant

Rowinsky Eric K

Director · 2026-06-11

—

1,505 shares

Grant

Mantas Jesus B

Director · 2026-06-11

—

1,505 shares

Grant

LANGER SUSAN

Director · 2026-06-11

—

1,505 shares

77 more transactions on ProFull insider transaction history is a Pro feature.

Upgrade →